Idebenone treatment in patients with OPA1-mutant dominant optic atrophy

Idebenone Treatment In Leber's Hereditary Optic Neuropathy

(2011) V. Carelli et al.   BRAIN

A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathy

(2011) Thomas Klopstock et al.   BRAIN

The influence of axial length on retinal nerve fibre layer thickness and optic-disc size measurements by spectral-domain OCT

(2011) Giacomo Savini et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

NQO1-Dependent Redox Cycling of Idebenone: Effects on Cellular Redox Potential and Energy Levels

(2011) Roman H. Haefeli et al.   PLoS One

Multi-system neurological disease is common in patients with OPA1 mutations

(2010) P. Yu-Wai-Man et al.   BRAIN

Retinal Nerve Fiber Layer Thickness Measurement by Fourier-domain Optical Coherence Tomography: A Comparison Between Cirrus-HD OCT and RTVue in Healthy Eyes

(2010) Giacomo Savini et al.   JOURNAL OF GLAUCOMA

OPA1 Mutations Associated with Dominant Optic Atrophy Influence Optic Nerve Head Size

(2010) Piero Barboni et al.   OPHTHALMOLOGY

Mitochondrial optic neuropathies – Disease mechanisms and therapeutic strategies

(2010) Patrick Yu-Wai-Man et al.   PROGRESS IN RETINAL AND EYE RESEARCH

OPA1 (dys)functions

(2010) Thomas Landes et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders

(2009) Valerio Carelli et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS

Reversible optic neuropathy withOPA1exon 5b mutation

(2008) Karen Cornille et al.   ANNALS OF NEUROLOGY

The natural history of OPA1-related autosomal dominant optic atrophy

(2008) A C Cohn et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

The Molecular Mechanisms of OPA1-Mediated Optic Atrophy in Drosophila Model and Prospects for Antioxidant Treatment

(2008) Will Yarosh et al.   PLoS Genetics